Leveraging Real-World Evidence for Pediatric Medical Device Label Expansion: A Case Study in Surgical Cryoanalgesia

jpedsurg.org

Real-world evidence (RWE) has emerged as an increasingly critical component in the regulatory development and evaluation of medical devices. RWE refers to analyzed clinical data collected from real-world settings (Real-world data, or RWD), including various sources such as the EHR, insurance claims, and patient-generated data (i.e. wearable devices) among others. RWE can be used prospectively or retrospectively in multiple settings to inform decision-making regarding the usage of a device, improve post-market surveillance, and expedite device innovation [1].

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jul 2025 · 1 min read

In brief

This article examines how real-world evidence from electronic health records, claims data, and patient-generated sources can support regulatory label expansion for pediatric medical devices, using surgical cryoanalgesia as a practical example. It demonstrates RWE's role in accelerating device innovation and enhancing post-market surveillance in pediatric populations.

Real-world evidence (RWE) uses clinical data from EHRs, claims, and patient devices to inform medical device regulatory decisions.
RWE can accelerate pediatric device label expansion by providing evidence outside traditional clinical trials.
Post-market surveillance benefits from RWE by capturing device performance in diverse real-world patient populations.
Surgical cryoanalgesia demonstrates how RWE supports expanding device indications to pediatric populations.
RWE bridges the gap between controlled trials and actual clinical practice for device innovation and safety monitoring.

Written by the GCMD Library team from the article.

Read it at the source ↗